Why People Experience NMN So Differently

If you have ever compared notes with someone else taking NMN, you may have noticed something puzzling. One person reports a noticeable lift in energy within weeks. Another takes the same dose for months and feels almost nothing. Both are taking a real product and both are ageing. So why the difference?

Some of the answers are ordinary: dose, time-to-effect, absorption, and expectation all play a role. People absorbing less per capsule, expecting overnight results, or comparing a month of supplementation to a decade of fatigue are going to be disappointed. But there is also a deeper variable most discussions overlook - one that a 2019 human study now documents clearly: how much you move.

The fall in NAD+ with age is not theoretical. Direct measurements in human tissue, including skin biopsies across a wide age range, show a clear and progressive decline across adult life⁶. By the time most people are in their 40s or 50s, the cellular machinery that converts food into usable energy and repairs DNA damage is running with significantly less of the molecule it depends on.

Part of that decline comes from increased destruction. An enzyme called CD38, which consumes NAD+, becomes more active with age; the same research proposes that low-grade inflammation of ageing further drives this upregulation, though that link is mechanistically plausible rather than experimentally confirmed in humans⁷. So NAD+ is being broken down faster at the same time it is being produced more slowly. The deficit compounds in both directions.

This is also where formulation starts to matter. The more complete NAD+ boosters do not only supply more NAD+, they also curb the enzyme that destroys it. Apigenin, the CD38 inhibitor in For Youth's The Repair NMN supplement, is included for exactly this reason: it protects NAD+ on the breakdown side while NMN rebuilds it on the supply side.

What the standard narrative misses is that this decline is not inevitable at the same rate for everyone. Your lifestyle, and specifically how much you move, has a measurable effect on where your NAD+ sits relative to your biological age.

In 2019, de Guia and colleagues published a human study that looked at how exercise interacts with the age-related decline in NAD+ production capacity in skeletal muscle¹. The key enzyme they measured was NAMPT (nicotinamide phosphoribosyltransferase) - the rate-limiting step in the main pathway cells use to make NAD+. When NAMPT activity is high, cells produce NAD+ efficiently. When it is low, the whole downstream system runs short.

The study found that skeletal muscle NAMPT declined significantly with age - but it also found that exercise training reversed that decline almost completely. Older adults who completed 12 weeks of aerobic training saw muscle NAMPT increase by 28%; those who completed resistance training saw a 30% increase. Both restored NAMPT to levels seen in young individuals, but not above them. The same training produced smaller gains in younger subjects, confirming that the body responds most strongly to exercise precisely where the deficit is greatest.

The implication was striking: chronological age alone does not determine your NAD+ production capacity. Regularly active elderly people, in metabolic terms, had muscle tissue that behaved decades younger. Inactivity, not just the passage of time, was accelerating the deficit.

Earlier research had already shown that the gap between active and sedentary individuals is substantial even before age-related decline sets in. Costford and colleagues measured skeletal muscle NAMPT across four groups: trained athletes, sedentary lean individuals, sedentary obese individuals, and people with type 2 diabetes². Athletes had approximately twice the muscle NAMPT protein of the sedentary groups. The enzyme also correlated strongly with VO2max, mitochondrial content, and the maximum rate at which muscle could produce energy. When the lean sedentary group was put through three weeks of exercise training, muscle NAMPT rose by 127%. (That figure looks larger than the 28-30% gains above because the two studies used different populations, baselines, and measures, not because three weeks somehow beats twelve.)

The mechanism is now reasonably well understood. Exercise activates AMPK, a cellular energy sensor, which in turn induces NAMPT expression. Higher NAMPT raises NAD+, which fuels SIRT1 and SIRT3, the longevity enzymes responsible for mitochondrial biogenesis and cellular repair⁸. Regular exercise triggers a cascade that keeps the whole NAD+-sirtuin axis running at a higher level.

Sedentary people never pull that lever. Their NAMPT stays low, their NAD+ production is reduced at baseline, and as they age, the age-related decline piles on top of the inactivity-related deficit. They are losing ground from two directions simultaneously.

This is where the supplementation question becomes more precise. If exercise reliably raises NAMPT and restores NAD+ to youthful levels, someone who runs regularly, lifts weights, or stays consistently active is already generating much of the stimulus that NMN is designed to compensate for. Their deficiency is smaller. The signal from supplementation competes with a background that is already relatively healthy.

The person with the largest unmet need is the one who sits at a desk for eight hours, commutes, eats dinner, and sleeps. With desk jobs now the norm across much of the working population, that description fits a significant proportion of adults over 40. Their NAMPT is low. Their NAD+ is declining with no compensating signal from physical activity. By 3pm, the cellular energy shortfall is often felt directly: a drop in focus, a pull toward caffeine, a fatigue that sleep does not fully resolve.

NMN bypasses the NAMPT bottleneck entirely. NAMPT converts nicotinamide - found in food - into NMN. When you supplement with NMN directly, you skip that conversion step: the NMN is taken up by cells and converted to NAD+ by a separate enzyme family (NMNAT), regardless of how suppressed your NAMPT is. For someone whose NAMPT is low from years of inactivity and ageing, this is the key advantage: the supplementation route works even when the body's own production pathway is running slowly.

NMN supplementation works best where the gap is widest. A sedentary 40-year-old has lower NAMPT, possibly higher CD38 activity, and no exercise-driven compensatory signal. That is the profile where the supplementation literature shows its clearest results — and where the daily experience of fatigue and cognitive dulling is most likely to have a cellular explanation. It is also the profile where The Repair has the most room to help: NMN to rebuild NAD+, apigenin to limit its breakdown through CD38, and pterostilbene to keep the sirtuins that NAD+ fuels switched on.

The picture for active individuals is more nuanced, and the evidence points to yes - for different reasons.

A 2021 randomised, double-blind, placebo-controlled trial by Liao and colleagues enrolled amateur runners and found that NMN supplementation significantly improved aerobic capacity compared to placebo⁴. This directly contradicts the assumption that active people have no room to benefit. The mechanism differs: exercise raises NAMPT primarily in skeletal muscle, meaning active people have relatively healthy muscle NAD+ - but the brain, liver, immune cells, and other tissues have their own NAD+ requirements and do not benefit from a run the way muscle does. Whole-body NAD+ sufficiency is not the same as muscle-specific sufficiency.

There is also a demand-side argument. High-intensity exercise places enormous metabolic stress on cells: NAD+ is consumed rapidly during sustained aerobic effort to support energy production and repair. Athletes training near their aerobic ceiling may be depleting NAD+ faster than the body can replace it between sessions, even with NAMPT running at full capacity. For this group, NMN is not about correcting a deficiency from inactivity; it is about supporting a system that is being pushed hard.

So the honest answer for active people is: yes, benefit is plausible and there is direct RCT evidence supporting it - but the rationale is different from the sedentary case, and the effect size may be smaller in the tissues that exercise already covers.

Even within the active group, some people will feel little from NMN. Beyond activity level and NAMPT status, there are several other common explanations:

• Dose. Most early-access NMN products used 125-250mg doses. The clinical literature increasingly suggests higher doses may be needed for a felt effect. If you started low and stayed low, the dose may simply be insufficient.
• Time-to-effect. Blood NAD+ rises within days of starting NMN, but functional changes in energy metabolism take weeks to months. Judging a supplement at six weeks may be too early.
• Absorption variability. Oral NMN bioavailability varies between individuals due to differences in gut enzyme activity. One point worth stressing: every clinical trial that has shown a benefit used standard oral NMN, not sublingual or liposomal versions. Regular oral NMN at an adequate dose is the form the evidence actually supports.
• Expectation mismatch. If your NAD+ was already reasonable (young, active, healthy diet), a subjective energy lift may simply not register - cellular improvements in DNA repair and metabolic efficiency are real but invisible to how you feel day to day.

For highly active people who have optimised all of the above and still feel nothing from NMN, there is a genuinely different lever to consider: The V-Max, For Youth's urolithin A product. Urolithin A is produced from pomegranate and walnut polyphenols by gut bacteria, and is being studied for its role in cellular health through a pathway separate from NAD+ supply - an active area of research across multiple groups.

Producing urolithin A naturally takes two things most people are missing. First, the right gut bacteria - only around 40% of people carry the microbiome that can make meaningful amounts. Second, a diet that actually supplies the raw material, the polyphenols in pomegranate, walnuts and berries, for those bacteria to convert. Miss either gate and you produce little to none, which means the gap The V-Max targets is both real and common. For the already-fit person who runs regularly and has healthy NAMPT from training, this different mechanism - rather than adding more NAD+ substrate - is the more logical lever to explore next.

The Repair is For Youth's NMN product. Each capsule contains 450mg of NMN (as Uthever™, an enzymatically produced form), 50mg of apigenin (as ApiAge® Apigenin), and 50mg of pterostilbene. The formulation addresses the NAD+ system at three points rather than one.

NMN raises NAD+ by supplying the salvage pathway substrate directly. Apigenin inhibits CD38, the enzyme whose activity rises with age and inflammation, so less NAD+ gets consumed after it is made. Pterostilbene activates SIRT1, ensuring the NAD+ that is available is put to work in repair and energy pathways. For a sedentary individual whose NAMPT is suppressed, this combination addresses production, breakdown, and downstream activation together - covering the deficit from multiple angles rather than one.

The variation in how people respond to NMN is not random. A large part of it is explained by where each person sits on the NAMPT spectrum - determined not just by age but by how much they move. Active elderly individuals can have NAD+ production capacity comparable to people decades younger¹. Sedentary individuals, regardless of age, carry a suppressed baseline that compounds with every year of inactivity².

For the significant and growing population of adults whose days are built around sitting - whose NAMPT is low, and whose NAD+ decline has no exercise-driven counterweight - NMN has the most logical case and the most room to produce a noticeable effect.

For active people, benefit is real but different. For active people who still feel nothing despite optimising dose and duration, the mechanism that matters may not be NAD+ substrate supply at all.

The honest summary: NMN is not magic and it is not equally useful for everyone. But for the person who wonders why their energy feels different than it did ten years ago, and whose daily life offers no real physical challenge, the cellular explanation is now well documented - and so is the pathway supplementation targets.